🇺🇸 FDA

Company profile · Sponsor

4D

4D Molecular Therapeutics

FDMT · NYSE biotech EMERYVILLE, CA, USA
Pipeline
19
Drugs
0
Patents
8

Quick answer

4D (FDMT) is a biotech company. headquartered in EMERYVILLE, CA, USA. listed on NYSE. NovaPharmaNews links 19 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker FDMT
Exchange NYSE
Company type biotech
Headquarters EMERYVILLE, CA, USA
SEC CIK 0001650648

Pipeline (19)

Search pipeline →

  1. 4D-150 IVT (3E10 vg/eye)

    4D

    Macular Neovascularization Secondary to Age-Related Macular Degeneration

    phase 3 mab active

    1 trial

  2. 4D-150 IVT (3E10 vg/eye)

    4D

    Neovascular Age-Related Macular Degeneration (nAMD)

    phase 3 mab active

    1 trial

  3. DIFLUPREDNATE, Eylea 40 mg/mL solution for injection in pre-filled syringe, Eylea 40 mg/mL solution for injection in pre-filled syringe, 4D-150, Eylea 40 mg/mL solution for injection in pre-filled syringe, Eylea 40 mg/mL solution for injection in pre-filled syringe

    4D

    Macular neovascularization secondary to age-related macular degeneration (nAMD)

    phase 3 small molecule active

    1 trial

  4. 4D-125 IVT Injection

    4D

    X-Linked Retinitis Pigmentosa

    phase 2 mab active

    1 trial

  5. 4D-150 IVT

    4D

    Neovascular (Wet) Age-Related Macular Degeneration

    phase 2 mab active

    1 trial

  6. 4D-150 IVT

    4D

    Diabetic Macular Edema

    phase 2 mab active

    1 trial

  7. 4D-310

    4D

    Fabry Disease

    phase 2 mab active

    2 trials

  8. 4D-710

    4D

    Cystic Fibrosis Lung

    phase 2 mab active

    1 trial

  9. Blautix

    4D

    Irritable Bowel Syndrome

    phase 2 mab completed

    1 trial

  10. MRx-4DP0004

    4D

    COVID-19

    phase 2 small molecule terminated

    1 trial

  11. MRx0518

    4D

    Urothelial Carcinoma

    phase 2 small molecule terminated

    1 trial

  12. MRx0518

    4D

    Oncology

    phase 2 small molecule terminated

    1 trial

  13. 4D-110

    4D

    Choroideremia

    phase 1 mab active

    1 trial

  14. MRx-4DP0004

    4D

    Asthma

    phase 1 small molecule terminated

    1 trial

  15. MRx0029

    4D

    Idiopathic Parkinson Disease

    phase 1 mab terminated

    1 trial

  16. MRx0518

    4D

    Pancreatic Cancer

    phase 1 small molecule terminated

    1 trial

  17. MRx0518 Capsules

    4D

    Melanoma

    phase 1 small molecule active

    1 trial

  18. Training with 4D Motion Capture Device

    4D

    Stroke

    phase 1 other completed

    1 trial

  19. 4D

    4D

    Dietary Supplementation

    other completed

    1 trial

Patents (8)

Search patents →

  1. US 11840704

    Adeno-associated virus variant capsids and methods of use thereof

    Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11807868

    Adeno-associated variants, formulations and methods for pulmonary delivery

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11766487

    Treatments for retinal disease

    Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11766489

    Adeno-associated virus variant capsids and use for inhibiting angiogenesis

    Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11576983

    Treatments for retinal disease

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11524081

    Codon optimized REP1 genes and uses thereof

    Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11499166

    Adeno-associated variants, formulations and methods for pulmonary delivery

    Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11419949

    Adeno-associated virus variant capsids and methods of use thereof

    Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is 4D?

4D (FDMT) is a biotech company. headquartered in EMERYVILLE, CA, USA. listed on NYSE. NovaPharmaNews links 19 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does 4D sponsor?

We track 19 ClinicalTrials.gov-linked programs for 4D, including 4D-150 IVT (3E10 vg/eye) and 18 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does 4D company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.